Reuters logo
BRIEF-TG Therapeutics Inc Q4 loss per share $0.48
March 10, 2017 / 12:43 PM / 6 months ago

BRIEF-TG Therapeutics Inc Q4 loss per share $0.48

March 10 (Reuters) - TG Therapeutics Inc

* TG Therapeutics Inc announces fourth quarter and year-end 2016 financial results and business update

* Qtrly loss per share $0.48

* TG Therapeutics Inc - cash, cash equivalents, investment securities, and interest receivable were $45.0 million as of December 31, 2016

* Q4 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S

* TG Therapeutics Inc - cash, cash equivalents, as of Dec 31, 2016 will be sufficient to fund planned operations for approximately next 24 months Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below